Skip to main content
Premium Trial:

Request an Annual Quote

Keith Olson Leaves Guava; Betsy Humphreys Tapped as NLM Deputy Director; Scott Garrett is Beckman s New CEO; and Others

NEW YORK, Feb. 11 (GenomeWeb News) - Keith Olson has left Guava Technologies, according to Inside Bioassays, a GenomeWeb newsletter. He used to be the company's director of product commercialization. Olson has taken a position with Fremont, Calif.-based drug discovery firm DiscoverX. Earlier this month, Guava announced that its CEO, Rajen Dalal, had resigned.


Betsy Humphreys has been promoted to deputy director of the National Institutes of Health's National Library of Medicine, the parent institute for the National Center for Biotechnology Information. She has been NLM associate director for library operations since 1999, after joining the NLM in 1973. She holds a bachelor's degree in history from SmithCollege and a master's degree in library science from the Universityof Maryland.


Scott Garrett will become CEO of Beckman Coulter on Feb. 21, the company said last month. He succeeds John Wareham, who is retiring. Warehamwill continue as chairman of the board until April 7. Garrett also joined Beckman's board of directors on Jan. 17. He has been Beckman's president and chief operating officer since the end of 2003 and joined the company in 2002. Prior to that, he was CEO of Garrett Capital Advisors and CEO of Kendro Laboratory Products.


Mark Allen has been promoted to senior vice president and managing director of Tripos Discovery Research, a UK-based unit of Tripos, the St. Louis-based company said on Monday. He used to be vice president of operations. Allen succeeds Peter Hecht, who is leaving Tripos to become CEO of Oridis Biomed. Hecht will remain a scientific advisor to the company.


Following of MorphoSys' acquisition of Biogenesis, which has units in the UKand the US, John Coward will become chairman of the UKsubsidiary, Morphosys said last month. He used to be the managing director of Biogenesis UK. Joan Poehlman, former president of Biogenesis US, will remain president of that subsidiary.


Pieter Muntendam has become president of BG Medicine, formerly Beyond Genomics, the Waltham, Mass.-based company said last week. He holds an MD from LeidenUniversity in the Netherlands. Most recently, he led the biopharmaceutical and healthcare practice at NetNumina, a service company focusing on information technology to improve biopharma yield and efficiency.


Douglas Downing has been promoted to vice president of operations for Biolase of San Clemente, Calif., the company said recently. Downing, who joined the company in May, has been director of global operations. Prior to that, he was director of manufacturing for Becton Dickinson's bioscience division.


Kristen Anderson was named senior vice president of human resources for Abgenix, the company said recently. Previously, Andersonwas vice president of human resources at Applied Biosystems.


Jim Parina has joined Expression Analysis of Research Triangle Park, NC, as director of sales and business development, the company said last month. He previously was pharmaceutical business development manager for Applied Biosystems, and before that, worked in sales for PerkinElmer.


James Koziarz has joined the board of directors of Rubicon Genomics, the Ann Arbor, Mich.-based company said on Tuesday. He is the former corporate vice president for hepatitis and retrovirus research and development of Abbott Laboratories. Since leaving Abbott last year, he has been consulting with start-up companies.


Daniel Von Hoff and Raymond Woosley have joined the scientific advisory board of HTG, the Tucson, Ariz.-based company said on Monday. Von Hoff is a member of the National Cancer Advisory Board. Woosley is the vice president for health sciences at the Universityof Arizona and dean of the Collegeof Medicine.


Alexander Cappello has joined the board of directors of Benitec as a non-executive director, the company said last week. He is the chairman and CEO of Cappello Group, an investment company.


John Reed, Burnham Institute president and CEO, and a director of Stratagene, has been named as a director of California's new stem cell program.


In conjunction with of a recent  financing round, Chad Waite, a general partner of OVP Venture Partners, Steve Hnatiuk, a partner of Yaletown Venture Partners, and Maria Pacella, investment manager of GrowthWorks Capital, have joined the board of directors of GenoLogics Life Sciences Software, the Vancouver, Canada-based company said last week.


Gene Network Sciences has established a cardiovascular scientific advisory board, the Ithaca, New York-based company said last week. Charter members include: Charles Antzelevitch, executive director and director of research at the Masonic Medical Research Laboratory; Robert Gilmour, professor of physiology and associate dean for research and graduate education at the College of Veterinary Medicine at Cornell University; Leon Glass, chair in cardiology and professor of physiology at McGill University; Wouter-Jan Rappel, research scientist in the department of physics at the University of California, San Diego; and James Weiss, director of the Cardiovascular Research Laboratory at the University of California, Los Angeles.


Evolutionary biologist Ernst Mayr died last week at 100 year. After working as a curator of the American Museum of Natural History in New Yorkin the 1930s and 1940s, he joined HarvardUniversity's Faculty of Arts and Sciences in 1953 as professor of zoology. He also led Harvard's Museumof Comparative Zoologyfrom 1961 to 1970. Mayr was a major force in securing evolutionary biology's central role in the science. Born July 5, 1904, in Kempten, Germany, he earned a medical degree from the Universityof Greifswaldin 1925, earning a PhD 16 months later. He received the National Medal of Science in 1970, the Balzan Prize in 1983, the International Prize for Biology in 1994, and the Crafoord Prize in 1999.

The Scan

Driving Malaria-Carrying Mosquitoes Down

Researchers from the UK and Italy have tested a gene drive for mosquitoes to limit the spread of malaria, NPR reports.

Office Space to Lab Space

The New York Times writes that some empty office spaces are transforming into lab spaces.

Prion Pause to Investigate

Science reports that a moratorium on prion research has been imposed at French public research institutions.

Genome Research Papers on Gut Microbe Antibiotic Response, Single-Cell RNA-Seq Clues to Metabolism, More

In Genome Research this week: gut microbial response to antibiotic treatment, approach to gauge metabolic features from single-cell RNA sequencing, and more.